Short-acting sedative agents during endoscopic retrograde cholangiopancreatography : a review of clinical effectiveness and guidelines / authors, Kwakye Peprah, Melissa Severn, Charlotte Wells, Anusree Subramonian
Endoscopic retrograde cholangiopancreatography (ERCP) is essential in the diagnosis and treatment of pancreaticobiliary pathologies. The procedure may be performed under general anesthesia to keep patients stable or with moderate to deep levels of sedation and analgesia to minimize patient discomfort during the procedure. However, potential complications involving respiratory and cardiovascular conditions, which may be related to the level of sedation, may occur during the operation. Essential factors to consider concerning the level of sedation for ERCP procedure include patient tolerance, the presence of comorbidities, the endoscopist’s comfort and ease of the procedure, staff, equipment, and anesthesia support available in the endoscopy suite. It has been reported that one-third to one-half of patients undergoing ERCP under conscious sedation experience discomfort and pain. Thus, there is a need for a sedation method or regimen that offers efficacy and has an excellent safety profile regarding sedation-related side effects. This report aims to identify and summarize evidence on the clinical effectiveness of short-acting sedative agents for conscious sedation during ERCP. An additional objective is to synthesize evidence-based guidelines for moderate procedural sedation during ERCP..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
August 17, 2020 |
|---|---|
| Erschienen: |
Ottawa: Canadian Agency for Drugs and Technologies in Health ; August 17, 2020 |
| Ausgabe: |
Version 1.0. |
| Reihe: |
CADTH rapid response report: summary with critical appraisal |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Peprah, Kwakye [VerfasserIn] |
|---|
| Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
|---|
| Themen: |
Cholangiopancreatography, Endoscopic Retrograde |
|---|
| Anmerkungen: |
Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed May 3, 2021) |
|---|
| Umfang: |
1 online resource (1 PDF file (45 pages)) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1773182803 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1773182803 | ||
| 003 | DE-627 | ||
| 005 | 20230428011907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211011s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1773182803 | ||
| 035 | |a (DE-599)KEP068720548 | ||
| 035 | |a (NCBI)1774986 | ||
| 035 | |a (EBP)068720548 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Peprah, Kwakye |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Short-acting sedative agents during endoscopic retrograde cholangiopancreatography |b a review of clinical effectiveness and guidelines |c authors, Kwakye Peprah, Melissa Severn, Charlotte Wells, Anusree Subramonian |
| 250 | |a Version 1.0. | ||
| 264 | 1 | |a Ottawa |b Canadian Agency for Drugs and Technologies in Health |c August 17, 2020 | |
| 300 | |a 1 online resource (1 PDF file (45 pages)) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a CADTH rapid response report: summary with critical appraisal | |
| 500 | |a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed May 3, 2021) | ||
| 520 | |a Endoscopic retrograde cholangiopancreatography (ERCP) is essential in the diagnosis and treatment of pancreaticobiliary pathologies. The procedure may be performed under general anesthesia to keep patients stable or with moderate to deep levels of sedation and analgesia to minimize patient discomfort during the procedure. However, potential complications involving respiratory and cardiovascular conditions, which may be related to the level of sedation, may occur during the operation. Essential factors to consider concerning the level of sedation for ERCP procedure include patient tolerance, the presence of comorbidities, the endoscopist’s comfort and ease of the procedure, staff, equipment, and anesthesia support available in the endoscopy suite. It has been reported that one-third to one-half of patients undergoing ERCP under conscious sedation experience discomfort and pain. Thus, there is a need for a sedation method or regimen that offers efficacy and has an excellent safety profile regarding sedation-related side effects. This report aims to identify and summarize evidence on the clinical effectiveness of short-acting sedative agents for conscious sedation during ERCP. An additional objective is to synthesize evidence-based guidelines for moderate procedural sedation during ERCP. | ||
| 650 | 2 | |a Cholangiopancreatography, Endoscopic Retrograde |x methods |0 https://id.nlm.nih.gov/mesh/D002760Q000379 | |
| 650 | 2 | |a Hypnotics and Sedatives |x analysis |0 https://id.nlm.nih.gov/mesh/D006993Q000032 | |
| 650 | 2 | |a Treatment Outcome |0 https://id.nlm.nih.gov/mesh/D016896 | |
| 650 | 2 | |a Practice Guidelines as Topic |0 https://id.nlm.nih.gov/mesh/D017410 | |
| 655 | 2 | |a Systematic Review |0 https://id.nlm.nih.gov/mesh/D000078182 | |
| 700 | 1 | |a Severn, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Wells, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Subramonian, Anusree |e verfasserin |4 aut | |
| 710 | 2 | |a Canadian Agency for Drugs and Technologies in Health, |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK565478/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
| 912 | |a ZDB-193-NCB | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a ISIL_DE-180 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 951 | |a BO | ||
| 980 | |2 22 |1 01 |x 0018 |b 3994079918 |h h64 NCBI |y zi06404 |z 21-10-21 | ||
| 980 | |2 40 |1 01 |x 0007 |b 3994006163 |h OLR-NCB-BOOKSHELF |y xsn |z 21-10-21 | ||
| 980 | |2 74 |1 01 |x 0354 |b 3999782439 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-11-21 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 3995675905 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 25-10-21 | ||
| 980 | |2 2009 |1 01 |x DE-180 |b 3987672323 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-10-21 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 3987762284 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 11-10-21 | ||
| 981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK565478/ | ||
| 981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK565478/ | ||
| 981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK565478/ | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK565478/ | ||
| 981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK565478/ | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
| 995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF | ||